Joel Raskin
2 presentations
-
FORVISIRVAT (SP-624), A FIRST-IN-HUMAN SIRT6 ACTIVATOR WITH AN EPIGENETIC MECHANISM OF ACTION, CURRENTLY IN A PHASE 2B-3 STUDY FOR THE TREATMENT OF MAJOR DEPRESSIVE DISORDER
-
T27. FORVISIRVAT (SP-624), A FIRST-IN-HUMAN SIRT6 ACTIVATOR WITH AN EPIGENETIC MECHANISM OF ACTION, CURRENTLY IN A PHASE 2B-3 STUDY FOR THE TREATMENT OF MAJOR DEPRESSIVE DISORDER